12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Wednesday. Notable gainers include Innovative Eyewear (LUCY), Reshape Lifesciences (RSLS), Sonoma Pharmaceuticals (SNOA), Apollomics (APLM), Onconetix (ONCO), and Chromocell Therapeutics (CHRO). Significant losers include TransCode Therapeutics (RNAZ), Cue Health (HLTH), Sharps Technology (STSS), Maravai LifeSciences (MRVI), Genetic Technologies (GENE), and Biohaven (BHVN).
May 29, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biohaven (BHVN) shares declined by 15.0% to $32.25, reducing its market value to $2.8 billion.
BHVN's significant price decline suggests negative market sentiment, likely resulting in further short-term losses.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Genetic Technologies (GENE) stock decreased by 16.28% to $1.8, reducing its market value to $5.7 million.
GENE's price decline indicates negative investor sentiment, likely leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Cue Health (HLTH) stock decreased by 28.92% to $0.06, reducing its market value to $10.2 million.
HLTH's significant price decline suggests negative market sentiment, likely resulting in further short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Maravai LifeSciences (MRVI) stock fell 16.56% to $8.99, reducing its market cap to $1.1 billion.
MRVI's significant price decline suggests negative market sentiment, likely resulting in further short-term losses.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics (RNAZ) shares declined by 32.0% to $1.32, reducing its market value to $8.7 million.
RNAZ's significant price decline indicates negative investor sentiment, likely leading to further short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sharps Technology (STSS) stock declined by 22.36% to $0.4, reducing its market value to $6.2 million.
STSS's price decline indicates negative investor sentiment, likely leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Apollomics (APLM) shares increased by 28.89% to $0.34, boosting its market value to $36.7 million.
APLM's significant price increase suggests strong investor interest, likely driving further short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Chromocell Therapeutics (CHRO) shares increased by 24.99% to $1.7, raising its market cap to $9.8 million.
CHRO's significant price increase suggests strong investor interest, likely driving further short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Innovative Eyewear (LUCY) stock surged by 173.2% to $1.12, significantly increasing its market value.
The substantial increase in LUCY's stock price indicates strong investor interest, likely driving further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Onconetix (ONCO) shares moved upwards by 25.07% to $0.2, increasing its market value to $4.5 million.
ONCO's price increase indicates positive market sentiment, likely leading to short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences (RSLS) stock rose by 53.94% to $0.32, boosting its market cap to $7.5 million.
RSLS's significant price increase suggests positive market sentiment, likely leading to short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Sonoma Pharmaceuticals (SNOA) stock increased by 34.56% to $0.27, raising its market cap to $4.2 million.
The rise in SNOA's stock price indicates positive investor sentiment, likely resulting in short-term gains.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100